Comparative Pharmacology
Head-to-head clinical analysis: COACTIN versus DEXASPORIN.
Peer-Reviewed Evidence
Head-to-head clinical analysis: COACTIN versus DEXASPORIN.
COACTIN vs DEXASPORIN
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Coactin (mecillinam) is a beta-lactam antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding protein 2 (PBP2) in gram-negative bacteria, leading to the formation of spheroplasts and cell lysis.
Dexasporin is a synthetic corticosteroid with potent anti-inflammatory and immunosuppressive properties. It binds to the glucocorticoid receptor, leading to modulation of gene expression and inhibition of pro-inflammatory mediators such as prostaglandins and leukotrienes.
400 mg orally every 6-8 hours with a full glass of water.
1 to 2 mg/kg intramuscular or intravenous every 8 hours.
None Documented
None Documented
Terminal elimination half-life: 1.0-1.5 hours in adults with normal renal function; prolonged to 2-6 hours in renal impairment; clinically requires frequent dosing or dose adjustment in renal failure.
3-4 hours (prolonged to 10-15 hours in renal impairment; monitor CrCl <30 mL/min)
Renal: approximately 70-80% as unchanged drug via glomerular filtration and tubular secretion; biliary/fecal: less than 10% as metabolites and unchanged drug.
Renal excretion (80-90% unchanged), biliary/fecal (10-20%)
Category C
Category C
Antibiotic Combination
Corticosteroid/Antibiotic Combination